SVP, DEV & HEAD OF IRE OFFICECIK 0002012524
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Miller AineSVP, DEV & HEAD OF IRE OFFICE |  TBPHTheravance Biopharma, Inc.Disposition to issuer | D | — 93.1K sh | Sep 24, 2026 traded Sep 23, 2026 | |
Miller AineSVP, DEV & HEAD OF IRE OFFICE |
| TBPHTheravance Biopharma, Inc. Disposition to issuer |
| D |
| — 37.5K sh |
| Sep 24, 2026 traded Sep 23, 2026 |
| 9 | Miller AineSVP, DEV & HEAD OF IRE OFFICE | TBPHTheravance Biopharma, Inc. Disposition to issuer | D | — 96.7K sh | Sep 24, 2026 traded Sep 23, 2026 |
| 12 | Miller AineSVP, DEV & HEAD OF IRE OFFICE | TBPHTheravance Biopharma, Inc. Tax withholding | F | $106K 6,258 sh | Aug 24, 2026 traded Aug 20, 2026 |
| 13 | Miller AineSVP, DEV & HEAD OF IRE OFFICE | TBPHTheravance Biopharma, Inc. Grant or award | A | — 18.8K sh | Jun 23, 2026 traded Jun 19, 2026 |
| 12 | Miller AineSVP, DEV & HEAD OF IRE OFFICE | TBPHTheravance Biopharma, Inc. Tax withholding | F | $113K 6,827 sh | May 22, 2026 traded May 20, 2026 |
| 19 | Miller AineSVP, DEV & HEAD OF IRE OFFICE | TBPHTheravance Biopharma, Inc. Tax withholding | F | $331K 16.9K sh | Feb 24, 2026 traded Feb 20, 2026 |
| 12 | Miller AineSVP, DEV & HEAD OF IRE OFFICE | TBPHTheravance Biopharma, Inc. Tax withholding | F | $125K 6,989 sh | Nov 24, 2025 traded Nov 20, 2025 |